Home/Filings/4/0001127602-22-025334
4//SEC Filing

Kullman Ellen Jamison 4

Accession 0001127602-22-025334

CIK 0000318154other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 9:18 PM ET

Size

5.2 KB

Accession

0001127602-22-025334

Insider Transaction Report

Form 4
Period: 2022-11-08
Transactions
  • Award

    Common Stock

    2022-11-08+222.30610,112.981 total
Footnotes (2)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.
  • [F2]These shares include 830 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001303141

Filing Metadata

Form type
4
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 9:18 PM ET
Size
5.2 KB